{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:49:09Z","timestamp":1770976149156,"version":"3.50.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":324,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"B\u00f6rjeson"},{"name":"Emil and Ragna Foundation"},{"name":"Tore Nilson Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>While statins are routinely prescribed to prevent cardiovascular diseases, their effects on brain alterations remain largely unknown. Very few studies have examined the differences in brain volumes between statin users and non-users, and existing research has yielded inconsistent results. This cross-sectional study aims to investigate the association between statin use at baseline and global and specific brain volumes measured 9 years later in a large population-based sample of middle-aged and older adults. Participants from the UK Biobank without neurological and psychiatric disorders consisted of 3285 statin users (mean 60 years and 69% males) and 36 229 non-users (mean 55 years and 46% males). We used linear models to estimate the mean volumetric differences between statin users and non-users while adjusting for UK Biobank assessment centre, age, sex, ethnicity, education, apolipoprotein E \u025b4 status, Townsend deprivation index, antidepressant use, intracranial volume, lifestyle factors (alcohol intake frequency, smoking and physical activity) and health-related conditions (body mass index, blood pressure, diabetes, coronary heart disease, stroke, head injury, depression and insomnia). Moreover, mediation analysis was performed to evaluate whether the association between statin use and global brain volumes was mediated by total serum cholesterol concentration. Statin use was associated with lower grey matter volume [\u03b2 = \u22121575\u2005mm3 (\u22122358, \u2212791)], with 20% of this association mediated by total serum cholesterol concentration. Statin use was also associated with lower peripheral cortical grey matter volumes [\u03b2 = \u22121448\u2005mm3 (\u22122227, \u2212668)] and higher white matter hyperintensity [\u03b2 = 0.11\u2005mm3 (0.07, 0.15)]. However, white matter volume did not differ significantly between statin users and non-users. Further analyses revealed that volumes of thalamus, pallidum, hippocampus, nucleus accumbens and other regions of the temporal lobe were smaller among statin users compared with non-users. This study showed that statin use is associated with higher white matter hyperintensity volumes and lower total and peripheral cortical grey matter volumes 9 years later, indicative of the brain\u2019s ageing process. Moreover, the observed grey matter alterations were partially explained by statin-induced total serum cholesterol reduction. This study emphasizes the potential direct and indirect effects of statins on brain volume.<\/jats:p>","DOI":"10.1093\/braincomms\/fcae417","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T22:35:08Z","timestamp":1732142108000},"source":"Crossref","is-referenced-by-count":2,"title":["Statin use is associated with higher white matter hyperintensity volumes and lower grey matter volumes"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4070-1229","authenticated-orcid":false,"given":"M\u00e9lissa","family":"Gentreau","sequence":"first","affiliation":[{"name":"Functional Pharmacology and Neuroscience, Department of Surgical Sciences, University of Uppsala , 751 23 Uppsala ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maud","family":"Miguet","sequence":"additional","affiliation":[{"name":"Functional Pharmacology and Neuroscience, Department of Surgical Sciences, University of Uppsala , 751 23 Uppsala ,","place":["Sweden"]},{"name":"Sport, Physical Activity, Rehabilitation and Movement for Performance and Health (SAPR\u00e9M), Universit\u00e9 d\u2019Orl\u00e9ans , 45067 Orl\u00e9ans ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oreste","family":"Affatato","sequence":"additional","affiliation":[{"name":"Functional Pharmacology and Neuroscience, Department of Surgical Sciences, University of Uppsala , 751 23 Uppsala ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gull","family":"Rukh","sequence":"additional","affiliation":[{"name":"Functional Pharmacology and Neuroscience, Department of Surgical Sciences, University of Uppsala , 751 23 Uppsala ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helgi Birgir","family":"Schi\u00f6th","sequence":"additional","affiliation":[{"name":"Functional Pharmacology and Neuroscience, Department of Surgical Sciences, University of Uppsala , 751 23 Uppsala ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"2024122016275990500_fcae417-B1","doi-asserted-by":"crossref","first-page":"111575","DOI":"10.1016\/j.mad.2021.111575","article-title":"Brain aging mechanisms with mechanical manifestations","volume":"200","author":"Blinkouskaya","year":"2021","journal-title":"Mech Ageing Dev."},{"key":"2024122016275990500_fcae417-B2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","article-title":"White matter hyperintensities, cognitive impairment and dementia: An update","volume":"11","author":"Prins","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"2024122016275990500_fcae417-B3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1212\/WNL.0000000000011829","article-title":"White matter hyperintensities: How much (and what shape) is too much?","volume":"96","author":"Yassi","year":"2021","journal-title":"Neurology"},{"key":"2024122016275990500_fcae417-B4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1212\/WNL.0b013e318227b227","article-title":"Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline","volume":"77","author":"Debette","year":"2011","journal-title":"Neurology"},{"key":"2024122016275990500_fcae417-B5","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/eurheartj\/ehz100","article-title":"Associations between vascular risk factors and brain MRI indices in UK Biobank","volume":"40","author":"Cox","year":"2019","journal-title":"Eur Heart J"},{"key":"2024122016275990500_fcae417-B6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jcmg.2023.01.016","article-title":"Ischemic heart disease and vascular risk factors are associated with accelerated brain aging","volume":"16","author":"Rauseo","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024122016275990500_fcae417-B7","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2024122016275990500_fcae417-B8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/978-90-481-8622-8_18","article-title":"Cholesterol and myelin biogenesis","volume":"51","author":"Saher","year":"2010","journal-title":"Subcell Biochem"},{"key":"2024122016275990500_fcae417-B9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41582-023-00864-5","article-title":"The translational potential of cholesterol-based therapies for neurological disease","volume":"19","author":"Valenza","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"2024122016275990500_fcae417-B10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archneur.60.4.510","article-title":"Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease","volume":"60","author":"Vega","year":"2003","journal-title":"Arch Neurol"},{"key":"2024122016275990500_fcae417-B11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.steroids.2004.03.012","article-title":"High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in Guinea pigs","volume":"69","author":"L\u00fctjohann","year":"2004","journal-title":"Steroids"},{"key":"2024122016275990500_fcae417-B12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease: Pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"2024122016275990500_fcae417-B13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: Far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2024122016275990500_fcae417-B14","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.neurobiolaging.2009.04.021","article-title":"Apolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessment","volume":"32","author":"Schipper","year":"2011","journal-title":"Neurobiol Aging."},{"key":"2024122016275990500_fcae417-B15","doi-asserted-by":"crossref","first-page":"118966","DOI":"10.1016\/j.neuroimage.2022.118966","article-title":"Association of APOE \u03b54 with cerebral gray matter volumes in non-demented older adults: The MEMENTO cohort study","volume":"250","author":"R\u00e9gy","year":"2022","journal-title":"Neuroimage"},{"key":"2024122016275990500_fcae417-B16","first-page":"94","article-title":"Statin usage increases white matter hyperintensities: A post hoc analysis of SPRINT-MIND","volume":"28","author":"Goldstein","year":"2023","journal-title":"Neurologist"},{"key":"2024122016275990500_fcae417-B17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s00415-009-5008-7","article-title":"Effects of statins on the progression of cerebral white matter lesion: Post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study","volume":"256","author":"Mok","year":"2009","journal-title":"J Neurol"},{"key":"2024122016275990500_fcae417-B18","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2019.09.041","article-title":"Effects of statins on memory, cognition, and brain volume in the elderly","volume":"74","author":"Samaras","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2024122016275990500_fcae417-B19","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1212\/01.WNL.0000161844.00797.73","article-title":"Effect of pravastatin on cerebral infarcts and white matter lesions","volume":"64","author":"ten Dam","year":"2005","journal-title":"Neurology"},{"key":"2024122016275990500_fcae417-B20","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/acn3.51421","article-title":"Effects of simvastatin on white matter integrity in healthy middle-aged adults","volume":"8","author":"Vogt","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"2024122016275990500_fcae417-B21","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jamda.2018.05.025","article-title":"Effect of low-dose statins and apolipoprotein E genotype on cerebral small vessel disease in older hypertensive patients: A subgroup analysis of a randomized clinical trial","volume":"19","author":"Ji","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"2024122016275990500_fcae417-B22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41440-018-0165-7","article-title":"Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: A randomized, double-blind and placebo-controlled clinical trial","volume":"42","author":"Zhang","year":"2019","journal-title":"Hypertens Res"},{"key":"2024122016275990500_fcae417-B23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/153331750401900506","article-title":"Statin use and hippocampal volumes in elderly subjects at risk for Alzheimer\u2019s disease: A pilot observational study","volume":"19","author":"Doraiswamy","year":"2004","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"2024122016275990500_fcae417-B24","first-page":"CD009628","article-title":"Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer\u2019s disease in people with mild cognitive impairment","volume":"3","author":"Lombardi","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2024122016275990500_fcae417-B25","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/gerona\/glad163","article-title":"The effects of statins on cognitive performance are mediated by low-density lipoprotein, C-reactive protein, and blood glucose concentrations","volume":"78","author":"Gentreau","year":"2023","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024122016275990500_fcae417-B26","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2024122016275990500_fcae417-B27","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/nn.4393","article-title":"Multimodal population brain imaging in the UK Biobank prospective epidemiological study","volume":"19","author":"Miller","year":"2016","journal-title":"Nat Neurosci"},{"key":"2024122016275990500_fcae417-B28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.neuroimage.2017.10.034","article-title":"Image processing and quality control for the first 10,000 brain imaging datasets from UK Biobank","volume":"166","author":"Alfaro-Almagro","year":"2018","journal-title":"Neuroimage"},{"key":"2024122016275990500_fcae417-B29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","article-title":"FSL","volume":"62","author":"Jenkinson","year":"2012","journal-title":"NeuroImage"},{"key":"2024122016275990500_fcae417-B30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s10194-021-01356-x","article-title":"Major sex differences in migraine prevalence among occupational categories: A cross-sectional study using UK Biobank","volume":"22","author":"Affatato","year":"2021","journal-title":"J Headache Pain"},{"key":"2024122016275990500_fcae417-B31","volume-title":"Companion document for serum biomarker data","author":"Fry","year":"2019"},{"key":"2024122016275990500_fcae417-B32","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2174\/1570159X1304150831121909","article-title":"Brain structural effects of antidepressant treatment in major depression","volume":"13","author":"Dusi","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"2024122016275990500_fcae417-B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v059.i05","article-title":"Mediation: R package for causal mediation analysis","volume":"59","author":"Tingley","year":"2014","journal-title":"J Stat Softw"},{"key":"2024122016275990500_fcae417-B34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc: Ser B (Methodol)"},{"key":"2024122016275990500_fcae417-B35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"2024122016275990500_fcae417-B36","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/2515245920928009","article-title":"Visualization of brain statistics with R packages ggseg and ggseg3d","volume":"3","author":"Mowinckel","year":"2020","journal-title":"Adv Methods Pract Psychol Sci."},{"key":"2024122016275990500_fcae417-B37","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jalz.2014.11.003","article-title":"Statins and brain integrity in older adults: Secondary analysis of the health ABC study","volume":"11","author":"Nadkarni","year":"2015","journal-title":"Alzheimers Dement"},{"key":"2024122016275990500_fcae417-B38","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3233\/JAD-180446","article-title":"Statins and brain health: Alzheimer\u2019s disease and cerebrovascular disease biomarkers in older adults","volume":"65","author":"Ramanan","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"2024122016275990500_fcae417-B39","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1212\/01.wnl.0000182897.18229.ec","article-title":"Statins and cognitive function in the elderly: The cardiovascular health study","volume":"65","author":"Bernick","year":"2005","journal-title":"Neurology"},{"key":"2024122016275990500_fcae417-B40","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"2024122016275990500_fcae417-B41","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1037\/neu0000298","article-title":"Nonlinear associations between plasma cholesterol levels and neuropsychological function","volume":"30","author":"Wendell","year":"2016","journal-title":"Neuropsychology"},{"key":"2024122016275990500_fcae417-B42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/JAD-160826","article-title":"Updating the evidence on the association between serum cholesterol and risk of late-life dementia: Review and meta-analysis","volume":"56","author":"Anstey","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"2024122016275990500_fcae417-B43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41582-018-0070-3","article-title":"Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease","volume":"14","author":"Kivipelto","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"2024122016275990500_fcae417-B44","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/jpet.104.075028","article-title":"Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex","volume":"312","author":"Johnson-Anuna","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"2024122016275990500_fcae417-B45","first-page":"293","article-title":"Formation of oxysterols from different pools of cholesterol as studied by stable isotope technique: Cerebral origin of most circulating 24S-hydroxycholesterol in rats, but not in mice","volume":"1486","author":"Meaney","year":"2000","journal-title":"Biochim Biophys Acta (BBA)\u2014Mol Cell Biol Lipids"},{"key":"2024122016275990500_fcae417-B46","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","article-title":"Cholesterol homeostasis in human brain: Turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation","volume":"39","author":"Bj\u00f6rkhem","year":"1998","journal-title":"J Lipid Res."}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcae417\/60773800\/fcae417.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/6\/6\/fcae417\/60903901\/fcae417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/6\/6\/fcae417\/60903901\/fcae417.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T16:28:29Z","timestamp":1734712109000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcae417\/7905810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcae417","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024]]},"published":{"date-parts":[[2024]]},"article-number":"fcae417"}}